<DOC>
	<DOCNO>NCT00190879</DOCNO>
	<brief_summary>To investigate effect atomoxetine hydrochloride treat adult attention deficit hyperactivity disorder comorbid social anxiety disorder</brief_summary>
	<brief_title>Placebo-Controlled Study Atomoxetine Hydrochloride Treatment Adults With ADHD Comorbid Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>You must 18 65 year old . You must diagnose attention deficit hyperactivity disorder social anxiety disorder . You must able visit doctor 's office least 8 time 16 week period . You must agree participate test examination require study . You woman pregnant breastfeeding . You presently acute unstable medical illness . You history allergic reaction atomoxetine hydrochloride . You take medication permit study . Your physician discus . You take part another clinical research trial within last 30 day receive treatment drug last 30 day receive regulatory approval .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>